Candidal Vulvovaginitis: A Review of Causes, Symptoms, and Treatment
Clicks: 47
ID: 309184
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
13.8
/100
47 views
3 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #3 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In clinical practice, vulvovaginitis is a prevalent issue, management is frequently hampered by a long history of ineffective treatments based on preliminary diagnoses. We discuss the most prevalent causes of recurrent vulvovaginitis, the necessary measures to establish a diagnosis, from the medical history to the extra tests required and the best therapeutic alternatives. The dermatologist is particularly interested in infectious, irritating, allergic, and hormonal reasons. Infection is the most common cause of these processes a frequent reason for delayed therapy; we shall focus on infectious etiologies and diagnosis.
| Reference Key |
imported_1761926612_6904ddd463854
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Shourya Pratap |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2025 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.